Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Irvine › NPI 1851917405
Lab

Promis Diagnostics, INC.

Promis Diagnostics, INC. was paid $767K by Medicaid between Oct 2021 and May 2023, across 4 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 41% of everything it billed.

33Billing provider infoPROMIS DIAGNOSTICS, INC.
IRVINE, CA 92618
33aNPI1851917405assigned 06/19/2020
28Total paid$767K
24GClaims18,102
24DCodes billed4
24AFirst – last monthOct 2021 – May 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#207 of 561
Median peer was paid$222K
This provider vs. median3.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20212,490$68K
202210,373$323K
20235,239$376K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 41% 5,967 4,156 $316K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 40% 2,419 1,126 $309K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 16% 7,697 4,889 $122K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 2.7% 2,019 1,284 $20K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHWANG, DAVID (OWNER)
Same official

Other billing entities under HWANG, DAVID

Full network →
ProviderLocationPaid
David Chien-Ta Hwang O.D.IncIrvine, CA$10K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.